Breaking News, Collaborations & Alliances

VGXI Accepted into the BioMAP Consortium

Joins the ranks of more than 200+ member firms dedicated to expanding the U.S.’s biopharma industrial capabilities and bio-manufacturing output.

Author Image

By: Charlie Sternberg

Associate Editor

VGXI Inc., a contract developer and manufacturer (CDMO) specializing in nucleic acid biopharmaceuticals, has been accepted into the Biopharmaceutical Manufacturing Preparedness (BioMap) Consortium, an organization focused on expanding the United States’ biopharmaceutical industrial capabilities and bio-manufacturing output.   The BioMap Consortium is supported by the Pharmaceutical Countermeasure Infrastructure (PCI) Division and BioMap Branch of the Biomedical Advanced Research and Deve...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters